MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, VERA has $621,739K in assets. $122,042K in debts. $114,351K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1363.93%
Quick Ratio
1363.93%
Cash Ratio
253.27%
Debt to Asset Ratio
19.63%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other asset...
Liabilities Breakdown
    • Additionalpaid-incapital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
114,351 354,725 57,773 49,121
Marketable securities
482,409 359,864 439,616 507,706
Prepaid expenses and other assets, current
19,042 14,294 13,922 14,527
Total current assets
615,802 728,883 511,311 571,354
Property and equipment, net
-1,374 1,155 1,151
Operating lease right-of-use assets
-1,923 2,036 2,471
Prepaid expenses and other assets, noncurrent
-2,553 3,001 3,552
Other assets, noncurrent
5,937 ---
Total assets
621,739 734,733 517,503 578,528
Operating lease liabilities
-549 473 855
Accounts payable
13,909 21,898 17,950 13,157
Accrued expenses and other liabilities, current
31,240 31,008 23,457 19,542
Total current liabilities
45,149 53,455 41,880 33,554
Long-term debt
75,029 74,838 74,648 74,464
Operating lease liabilities, noncurrent
-1,919 2,095 2,233
Other liabilities, noncurrent
1,864 ---
Total liabilities
122,042 130,212 118,623 110,251
Class a common stock, 0.001 par value 500,000,000 shares authorized as of march 31, 2026 and december 31, 2025 71,730,090 and 71,267,429 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
72 71 64 64
Additionalpaid-incapital
1,381,678 1,364,529 1,067,703 1,057,161
Accumulated other comprehensive (loss) income
-156 786 881 527
Accumulated deficit
-881,897 -760,865 -669,768 -589,475
Total stockholders' equity
499,697 604,521 398,880 468,277
Total liabilities and stockholders' equity
621,739 734,733 517,503 578,528
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$482,409K Cash and cashequivalents$114,351K Prepaid expenses andother assets, current$19,042K Total current assets$615,802K Other assets,noncurrent$5,937K Total assets$621,739K Total liabilities andstockholders' equity$621,739K Total stockholders'equity$499,697K Total liabilities$122,042K Accumulated deficit-$881,897K Accumulated othercomprehensive (loss) income-$156K Additionalpaid-incapital$1,381,678K Long-term debt$75,029K Total currentliabilities$45,149K Other liabilities,noncurrent$1,864K Class a common stock,0.001 par value...$72K Accrued expenses andother liabilities,...$31,240K Accounts payable$13,909K

Vera Therapeutics, Inc. (VERA)

Vera Therapeutics, Inc. (VERA)